| Company name |
ORAGENICS |
| IPO date |
15/12/08 |
| ISIN code |
US6840231046 |
| Euronext code |
US6840231046 |
| Market entry place |
| Paris |
|
|
| Subsector |
4573_Biotechnology |
| Market compartment |
Alternext |
|
|
| Website url |
http://www.onibiopharma.com |
| IPO type |
Direct trading procedure |
| Operation description |
Admission on Alternext 38,318,478 existing common shares representing the outstanding capital of ORAGENICS.
ORAGENICS, which commercial name is ONI BioPharma, is already listed on NYSE Alternext US. |
| Operation procedure |
- Number of securities to be listed: 38,318,478
- Reference price: Closing price of the share Oragenics, on the 12/12/2008 on NYSE Alternext US converted in EUR on the basis of EUR/USD exchange rate of the 12/12/2008. |
| Operation calendar |
December 15, 2008: listing of the shares issued by ORAGENICS |
|
|
| Listing sponsors |
BRYAN, GARNIER AND CO Ltd |
|
|
|
